☆ 4.5 Article

Clinical and pathological characterization of 158 consecutive and unselected oligometastatic breast cancers in a single institution

BREAST CANCER RESEARCH AND TREATMENT (2023)

Related references

Note: Only part of the references are listed.

Letter Oncology

Expert Discussion: Highlights from ABC6: Bridging the Gap and Insights in This First Virtual ABC Conference and from 10 Years ABC Consensus

Rachel Wuerstlein et al.

BREAST CARE (2022)

Add to Collection

Article Oncology

The continuing conundrum in oligometastatic breast carcinoma: A real-world data

Gangothri Selvarajan et al.

Summary: The optimal management of oligometastatic breast carcinoma is still undefined. This study aimed to identify prognostic factors and the effect of Locoregional treatment (LRT) on survival in oligometastatic breast carcinoma. The results showed that survival was influenced by oligometastatic disease, Ki67 < 50%, premenopausal status, and hormone therapy. The study highlights the importance of curative LRT to metastatic sites and primary tumor in improving the long-term survival of patients with oligometastatic breast carcinoma.

BREAST (2022)

Add to Collection

Review Oncology

Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective

Marc D. Piroth et al.

Summary: Evidence suggests that SBRT treatment in oligometastatic breast cancer shows positive effects on local tumor control and survival rates, but it remains unclear which patients benefit the most from this approach. Further studies are needed to prove the benefits of SBRT in oligometastatic breast cancer and to define appropriate selection criteria.

STRAHLENTHERAPIE UND ONKOLOGIE (2022)

Add to Collection

Article Oncology

NRG-BR002: A phase IIR/III trial of standard of care systemic therapy with or without stereotactic body radiotherapy (SBRT) and/or surgical resection (SR) for newly oligometastatic breast cancer (NCT02364557).

Steven J. Chmura et al.

JOURNAL OF CLINICAL ONCOLOGY (2022)

Add to Collection

Review Oncology

The oligometastatic spectrum in the era of improved detection and modern systemic therapy

Rohan R. Katipally et al.

Summary: This review reframes the oligometastatic phenotype as a dynamic state that can be improved with locally ablative, metastasis-directed therapy. The authors highlight important risk factors defining the metastatic spectrum and provide strategies for integrating local therapies with modern systemic treatments.

NATURE REVIEWS CLINICAL ONCOLOGY (2022)

Add to Collection

Article Oncology

Diagnosis, biology and epidemiology of oligometastatic breast cancer

Jean-Louis Lacaze et al.

Summary: Oligometastatic breast cancer (OMBC) lacks a standardized treatment strategy, with limited information provided by existing literature. Research on OMBC biological characteristics suggests a focus on circulating tumor cell counts, as well as development of studies on microRNAs, circulating tumor DNA, and genomic alterations.

BREAST (2021)

Add to Collection

Review Oncology

Stereotactic body radiotherapy to treat breast cancer oligometastases: A systematic review with meta-analysis

Gustavo A. Viani et al.

Summary: SABR for oligometastatic breast cancer is safe and effective, with high rates of local control and survival. Prospective design and bone-only metastases are significantly associated with better outcomes.

RADIOTHERAPY AND ONCOLOGY (2021)

Add to Collection

Article Oncology

Long-term outcomes of oligometastatic breast cancer patients treated with curative intent: an updated report

Eijiro Nagasaki et al.

Summary: This study retrospectively analyzed oligometastatic breast cancer (OMBC) patients and found that after excluding isolated locoregional recurrence cases, the overall survival rates at 20 and 25 years were 28.3% and 18.9% respectively, with a relapse-free rate of 26.7%. In multivariate analysis, single-organ involvement and three or fewer metastatic lesions per organ were associated with a longer progression-free interval and relapse-free interval.

BREAST CANCER (2021)

Add to Collection

Article Oncology

Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer

Tessa G. Steenbruggen et al.

Summary: Studies show that OMBC defined as MBC limited to 1-3 metastases is associated with favorable OS. In OMBC, local therapy of metastases was associated with better OS, particularly if patients were premenopausal or perimenopausal without lung metastases.

JNCI CANCER SPECTRUM (2021)

Add to Collection

Article Oncology

Characterization of Oligometastatic Disease in a Real-World Nationwide Cohort of 3447 Patients With de Novo Metastatic Breast Cancer

Tessa G. Steenbruggen et al.

Summary: In this study, oligo-metastatic breast cancer (OMBC) was defined as having 1-3 metastases, with more metastases being associated with poorer overall survival. Premenopausal and perimenopausal status, absence of lung metastases, and local therapy (surgery and/or radiotherapy) in addition to systemic therapy were significantly associated with better overall survival and progression-free survival in OMBC patients.

JNCI CANCER SPECTRUM (2021)

Add to Collection

Article Oncology

Local Treatment in Addition to Endocrine Therapy in Hormone Receptor-Positive and HER2-Negative Oligometastatic Breast Cancer Patients: A Retrospective Multicenter Analysis

Chihwan Cha et al.

BREAST CARE (2020)

Add to Collection

Review Oncology

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

Matthias Guckenberger et al.

LANCET ONCOLOGY (2020)

Add to Collection

Article Oncology

Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008-2016

Elise Deluche et al.

EUROPEAN JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop

James B. Yu et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)

Add to Collection

Article Oncology

Clinical features and prognostic factors for extracranial oligometastatic breast cancer in China

Bo Lan et al.

INTERNATIONAL JOURNAL OF CANCER (2020)

Add to Collection

Article Oncology

5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5)

F. Cardoso et al.

ANNALS OF ONCOLOGY (2020)

Add to Collection

Review Oncology

Prognostic factors in patients with oligometastatic breast cancer - A systematic review

Annemiek van Ommen-Nijhof et al.

CANCER TREATMENT REVIEWS (2020)

Add to Collection

Article Oncology

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

Yolande Lievens et al.

RADIOTHERAPY AND ONCOLOGY (2020)

Add to Collection

Review Oncology

Cancer progression and the invisible phase of metastatic colonization

Christoph A. Klein

NATURE REVIEWS CANCER (2020)

Add to Collection

Article Oncology

Oligometastatic breast cancer treated with hypofractionated stereotactic radiotherapy: Some patients survive longer than a decade

Michael T. Milano et al.

RADIOTHERAPY AND ONCOLOGY (2019)

Add to Collection

Article Medicine, General & Internal

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial

David A. Palma et al.

LANCET (2019)

Add to Collection

Article Multidisciplinary Sciences

Genomic characterization of metastatic breast cancers

Francois Bertucci et al.

NATURE (2019)

Add to Collection

Article Oncology

Radiological complete remission in HER2-positive metastatic breast cancer patients: what to do with trastuzumab?

T. G. Steenbruggen et al.

BREAST CANCER RESEARCH AND TREATMENT (2019)

Add to Collection

Article Medicine, General & Internal

Breast cancer

Nadia Harbeck et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Add to Collection

Review Oncology

Strategies and technical challenges for imaging oligometastatic disease: Recommendations from the European Organisation for Research and Treatment of Cancer imaging group

Nandita M. deSouza et al.

EUROPEAN JOURNAL OF CANCER (2018)

Add to Collection

Article Oncology

Radical radiation therapy for oligometastatic breast cancer: Results of a prospective phase II trial

Marco Trovo et al.

RADIOTHERAPY AND ONCOLOGY (2018)

Add to Collection

Article Oncology

Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer A Phase 2 Randomized Clinical Trial

Puneeth Iyengar et al.

JAMA ONCOLOGY (2018)

Add to Collection

Article Oncology

Patterns of Progression in Metastatic Estrogen Receptor Positive Breast Cancer: An Argument for Local Therapy

Patrick Kelly et al.

INTERNATIONAL JOURNAL OF BREAST CANCER (2017)

Add to Collection

Article Oncology

Imaging oligometastatic cancer before local treatment

James M. Franklin et al.

LANCET ONCOLOGY (2016)

Add to Collection

Article Oncology

The biology and treatment of oligometastatic cancer

Diane K. Reyes et al.

ONCOTARGET (2015)

Add to Collection

Article Oncology

Prognostic factors in breast cancer with extracranial oligometastases and the appropriate role of radiation therapy

Gyu Sang Yoo et al.

RADIATION ONCOLOGY JOURNAL (2015)

Add to Collection

Article Oncology

The oligometastatic state-separating truth from wishful thinking

David A. Palma et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2014)

Add to Collection

Article Pathology

Prognostic factors in patients with metastatic breast cancer at the time of diagnosis

Zhiyong Ren et al.

PATHOLOGY RESEARCH AND PRACTICE (2014)

Add to Collection

Article Oncology

Delineation of the neck node levels for head and neck tumors: A 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines

Vincent Gregoire et al.

RADIOTHERAPY AND ONCOLOGY (2014)

Add to Collection

Review Oncology

Stereotactic body radiotherapy for oligometastases

Alison C. Tree et al.

LANCET ONCOLOGY (2013)

Add to Collection

Article Oncology

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

A. S. Berghoff et al.

BRITISH JOURNAL OF CANCER (2012)

Add to Collection

Review Oncology

Stereotactic body radiotherapy treatment of extracranial metastases

Joseph K. Salama et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2012)

Add to Collection

Review Oncology

Possible clinical cure of metastatic breast cancer: lessons from our 30-year experience with oligometastatic breast cancer patients and literature review

Tadashi Kobayashi et al.

BREAST CANCER (2012)

Add to Collection

Meeting Abstract Oncology

Patterns of Distant Failure and Progression in Breast Cancer: Implications for the Treatment of Oligometastatic Disease

P. L. Dorn et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

Add to Collection

Article Oncology

Oligometastases revisited

Ralph R. Weichselbaum et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Add to Collection

Editorial Material Oncology

The seed and soil hypothesis revisited

Isaiah J. Fidler et al.

LANCET ONCOLOGY (2008)

Add to Collection

Review Biochemistry & Molecular Biology

Cancer metastasis:: Building a framework

Gaorav P. Gupta et al.

CELL (2006)

Add to Collection

Article Oncology

CT-based definition of thoracic lymph node stations: An atlas from the University of Michigan

O Chapet et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)

Add to Collection

Article Oncology

Breast cancer with synchronous metastases: Trends in survival during a 14-year period

F Andre et al.

JOURNAL OF CLINICAL ONCOLOGY (2004)

Add to Collection

© Peeref 2019-2024. All rights reserved.